Mitragynine Confirmation (Qualitative), Umbilical Cord Tissue
Use
This test is used as a reflex confirmation for mitragynine (an alkaloid of kratom) in umbilical cord tissue, indicating prenatal exposure in neonates. It supports detection of maternal kratom use through sampling of fetal umbilical cord tissue and provides reporting limit determination for each analysis in ng/g.
Special Instructions
Can only be ordered as a reflex test. Submitted specimen must be umbilical cord tissue; handling instructions specify refrigerated transport preferred for up to 7 days, or frozen for up to 14 days.
Limitations
Reporting limit is determined individually per analysis. As a qualitative confirmation test, it provides presence but not quantitation beyond detection limit. Additional limitations may exist per laboratory validation but are not specified here.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Tissue
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Only orderable as a reflex test.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 14 days |